PA8786301A1 - "un nuevo procedimiento para preparar acido 2-(3-{6-[2(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico" - Google Patents

"un nuevo procedimiento para preparar acido 2-(3-{6-[2(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico"

Info

Publication number
PA8786301A1
PA8786301A1 PA20088786301A PA8786301A PA8786301A1 PA 8786301 A1 PA8786301 A1 PA 8786301A1 PA 20088786301 A PA20088786301 A PA 20088786301A PA 8786301 A PA8786301 A PA 8786301A PA 8786301 A1 PA8786301 A1 PA 8786301A1
Authority
PA
Panama
Prior art keywords
methyl
metoxypyrimidin
diclorophenyl
penyl
ethylamine
Prior art date
Application number
PA20088786301A
Other languages
English (en)
Spanish (es)
Inventor
Reda G Hanna
Bag-Guo Huang
Elizabeth Secord
Matthew R Power
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PA8786301A1 publication Critical patent/PA8786301A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Catalysts (AREA)
PA20088786301A 2007-06-29 2008-06-27 "un nuevo procedimiento para preparar acido 2-(3-{6-[2(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico" PA8786301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94725607P 2007-06-29 2007-06-29

Publications (1)

Publication Number Publication Date
PA8786301A1 true PA8786301A1 (es) 2009-01-23

Family

ID=40226759

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088786301A PA8786301A1 (es) 2007-06-29 2008-06-27 "un nuevo procedimiento para preparar acido 2-(3-{6-[2(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico"

Country Status (11)

Country Link
US (1) US20100184979A1 (enExample)
EP (1) EP2170837B1 (enExample)
JP (1) JP2010532366A (enExample)
AR (1) AR067348A1 (enExample)
AT (1) ATE531699T1 (enExample)
CL (1) CL2008001913A1 (enExample)
PA (1) PA8786301A1 (enExample)
PE (1) PE20090428A1 (enExample)
TW (1) TW200922927A (enExample)
UY (1) UY31192A1 (enExample)
WO (1) WO2009006086A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5833626B2 (ja) * 2010-03-23 2015-12-16 サイノファーム タイワン リミテッド ラパチニブの調製プロセス及び中間体
CN104592137B (zh) * 2014-11-04 2016-09-14 江苏大学 2,2’,2”-[1,3,5-三嗪-2,4,6-三巯基]三丙酸及其合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2005000795A (es) 2004-10-15 2010-08-19 Aventis Pharma Inc Pirimidinas como antagonistas del receptor de prostaglandina d2
GT200600457A (es) * 2005-10-13 2007-04-27 Aventis Pharma Inc Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2
AR074776A1 (es) * 2008-12-18 2011-02-09 Sanofi Aventis Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente

Also Published As

Publication number Publication date
EP2170837B1 (en) 2011-11-02
JP2010532366A (ja) 2010-10-07
EP2170837A2 (en) 2010-04-07
US20100184979A1 (en) 2010-07-22
TW200922927A (en) 2009-06-01
WO2009006086A3 (en) 2009-03-12
ATE531699T1 (de) 2011-11-15
UY31192A1 (es) 2009-01-30
PE20090428A1 (es) 2009-05-04
AR067348A1 (es) 2009-10-07
WO2009006086A2 (en) 2009-01-08
CL2008001913A1 (es) 2009-01-16

Similar Documents

Publication Publication Date Title
DK3686193T3 (da) 2-(2,4,5-substitueret anilino)pyrimidinforbindelser
ZA201001818B (en) Derivavtives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
EA201000269A1 (ru) Новые гербициды
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
EA201101148A1 (ru) Новые гербициды
IL192752A0 (en) Quick coupling particularly for the stock of a portable weapon
SI2057122T1 (sl) Derivati 4-(2-amino-1-hidroksietil)fenola kot agonisti beta2-adrenergičnega receptorja
UA103625C2 (en) 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides
MY161132A (en) Novel herbicides
TW200736195A (en) Methods for preparing sulfonamide substituted alcohols and intermediates thereof
MX2010001364A (es) Derivados de ciclopentandiona puenteados triciclicos como herbicidas.
EA201101146A1 (ru) Новые гербициды
EA201101099A1 (ru) Гербициды, полученные из циклопентадиона
EA201100920A1 (ru) Новые гербициды
CU20090141A7 (es) Compuestos 2-amino pirimidina
ZA201004009B (en) Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
BRPI0815754A2 (pt) métodos para preparar compostos à base de 4-fenil-6-(2,2,2-trifluoro-1-feniletóxi)pirimidina
TN2009000536A1 (en) Novel herbicides
CL2011002278A1 (es) Proceso para la preparacion de (e)-n-(4-(3-ter-butil-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-2-metoxiestiril)fenil)metansulfonamida o su sal por reduccion del correspondiente etinilo; y los compuestos intermediarios considerados.
PA8786301A1 (es) "un nuevo procedimiento para preparar acido 2-(3-{6-[2(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico"
TN2010000094A1 (en) Novel herbicides
BRPI0919188A2 (pt) processo para a purificação de metanol por destilação.
UY31191A1 (es) Proceso para la preparación de ácido (2r)-2-[4-(7-bromo-2-quinoliloxi)fenoxi]propanoico
UA35653U (en) 2-(4-aryliden-2,5-dioxyimidazolidine-1-yl)-n-arylazetamides having antileukemic activity
UA87255C2 (en) Use of n-(2-(morpholine-4-yl)propyl)-2-naphthalimidoacetamide as interferone-inducing antiviral agent